Show simple item record

dc.creatorYamamoto, K.A.
dc.creatorBlackburn, K.
dc.creatorMigowsk, E.
dc.creatorGoshe, M. B.
dc.creatorBrown, D. T.
dc.creatorFerreira, D. F.
dc.creatorSoares, M. R.
dc.date.accessioned2020-09-17T17:37:56Z
dc.date.available2020-09-17T17:37:56Z
dc.date.created2020
dc.identifier.issn2045 2322spa
dc.identifier.otherhttps://doi.org/10.1038/s41598-020-71634-2spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/13373
dc.description.abstractNitazoxanide (NTZ) is efective against helminths and numerous microorganisms, including bacteria and viruses. In vivo, NTZ is metabolized into Tizoxanide (TIZ), which is the active circulating metabolite. With the emergence of SARS-Cov-2 as a Pandemic agent, NTZ became one of the molecules already approved for human use to engage clinical trials, due to results in vitro showing that NTZ was highly efective against the SARS-Cov-2, agent of COVID-19.There are currently several ongoing clinical trials mainly in the USA and Brazil involving NTZ due not only to the in vitro results, but also for its long-known safety. Here, we study the response ofVero cells toTIZ treatment and unveil possible mechanisms for its antimicrobial efect, using a label-free proteomic approach (LC/ MS/MS) analysis to compare the proteomic profle between untreated- andTIZ-treated cells. Fifteen diferentially expressed proteins were observed related to various biological processes, including translation, intracellular trafcking, RNA processing and modifcation, and signal transduction.The broad antimicrobial range ofTIZ points towards its overall efect in lowering cell metabolism and RNA processing and modifcation.The decreased levels of FASN, HNRNPH and HNRNPK with the treatment appear to be important for antiviral activity.spa
dc.format.extent10 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherScientific reportsspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectProteomic analysisspa
dc.subjectTizoxanidespa
dc.subjectVero cellsspa
dc.titleQuantitative proteomic analysis of the tizoxanide efect in vero cellsspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1038/s41598-020-71634-2spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record